XML 100 R66.htm IDEA: XBRL DOCUMENT v3.23.2

COMMITMENTS AND CONTINGENCIES (Details) $ in Millions	Aug. 03, 2023 USD ($)	Dec. 21, 2020 patent	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Loss Contingencies [Line Items]
Legal charges pending settlement			$ 77.5	$ 0.0
Raygen, Inc vs. Myriad Women's Health, Inc.
Loss Contingencies [Line Items]
Number of patents allegedly infringed | patent		2
Myriad Genetics, Inc. Securities Litigation | Pending Litigation
Loss Contingencies [Line Items]
Legal charges pending settlement			$ 77.5
Myriad Genetics, Inc. Securities Litigation | Subsequent Event
Loss Contingencies [Line Items]
Settlement agreement	$ 77.5
Litigation settlement, amount awarded to other party, cash	20.0
Litigation settlement, amount awarded to other party, common stock	57.5
Litigation settlement, amount awarded to other party, elected payment	$ 57.5
Litigation settlement, period to determine awarded common stock	10 days
Litigation settlement, number of outstanding shares, common stock	5.00%

X

- Definition

Litigation Settlement, Amount Awarded To Other Party, Cash

+ References

No definition available.

+ Details

Name:	mygn_LitigationSettlementAmountAwardedToOtherPartyCash
Namespace Prefix:	mygn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Litigation Settlement, Amount Awarded To Other Party, Common Stock

+ References

No definition available.

+ Details

Name:	mygn_LitigationSettlementAmountAwardedToOtherPartyCommonStock
Namespace Prefix:	mygn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Litigation Settlement, Amount Awarded To Other Party, Elected Payment

+ References

No definition available.

+ Details

Name:	mygn_LitigationSettlementAmountAwardedToOtherPartyElectedPayment
Namespace Prefix:	mygn_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Litigation Settlement, Percentage Of Outstanding Shares, Common Stock

+ References

No definition available.

+ Details

Name:	mygn_LitigationSettlementPercentageOfOutstandingSharesCommonStock
Namespace Prefix:	mygn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Litigation Settlement, Period To Determine Awarded Common Stock

+ References

No definition available.

+ Details

Name:	mygn_LitigationSettlementPeriodToDetermineAwardedCommonStock
Namespace Prefix:	mygn_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_LitigationReserveCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482425/460-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	srt_LitigationCaseAxis=mygn_RaygenIncVersusMyriadWomensHealthIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_LitigationCaseAxis=mygn_MyriadGeneticsIncSecuritiesLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: